The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: a systematic review and meta-analysis. (2024)
“remdesivir treatment during acute COVID-19 did not significantly impact long COVID incidence (OR, 0.33; 95% CI, 0.09e1.23; p 0.0995)”